Peptide-based inhibition of CD44v6 renders liver carcinomas more susceptible to therapeutic intervention
{{output}}
Cluster of differentiation 44 variant 6 (CD44v6) has been described in various types of cancer, including liver cancer. Despite significant advancements in cancer therapy, there is still an urgent medical need for new therapeutic strategies for the treatment o... ...